Congress·In Committee·S. 3064
Relief of Chronic Pain Act of 2025
Congress Targets Lower Medicare Drug Costs and Fewer Hurdles for Some Non-Opioid Chronic Pain Meds
⏸
Stalled
No legislative action in over 90 days.
Legislative Progress
Senate
Key Points
- Starting Jan. 1, 2026, Medicare Part D plans would have to waive the deductible for certain qualifying non-opioid chronic pain drugs.
- These qualifying drugs would have to be put on the plan’s lowest cost-sharing tier, meaning patients should pay less out of pocket.
- The bill bars Medicare drug plans from requiring people to try an opioid first before they can get these qualifying non-opioid drugs.
- The bill also bans prior authorization for these qualifying non-opioid drugs, which could reduce delays and paperwork for patients and doctors.
- It applies only to specific chronic pain conditions listed in the bill, like fibromyalgia, neuropathic pain, and diabetic nerve pain lasting over 3 months.
Impact Analysis
Personal Impact
How this policy affects specific groups of people
Positive Impacts(1)
Milestones
2 milestones2 actions
Oct 28, 2025
Read twice and referred to the Committee on Finance.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Oct 28, 2025
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
News
No related news coverage found for this legislation yet.
Source Information
Document Type
Congressional Bill
Official Title
Relief of Chronic Pain Act of 2025
Bill NumberS 3064
Congress119th Congress
ChamberSenate
Latest ActionRead twice and referred to the Committee on Finance.
Data Sources
Sponsor
Cosponsors
(1)D: 1
Analysis generated by AI. Always verify with official sources.